Homepage
Medication Guide
What is Canagliflozin Hydrochloride (Canaglu)?
Canagliflozin Hydrochloride (Canaglu) is a novel sodium-glucose cotransporter 2 (SGLT2) inhibitor developed by Bayer, primarily indicated for the treatment of type 2 diabetes mellitus. As a key member...
508
Monday, November 24th, 2025, 10:16
How to Purchase Canagliflozin Hydrochloride (Canaglu)?
Canagliflozin Hydrochloride (Canaglu), as a new-generation oral hypoglycemic agent, plays an important role in the treatment of type 2 diabetes mellitus.How to Purchase Canagliflozin Hydrochloride (Ca...
507
Monday, November 24th, 2025, 10:00
Side Effects of Lurbinectedin (Zepzelca)
Lurbinectedin (Zepzelca) is an alkylating agent indicated for the maintenance treatment of extensive-stage small cell lung cancer (ES-SCLC) and for the treatment of patients with metastatic small cell...
510
Monday, November 24th, 2025, 09:56
What are the Precautions for Lurbinectedin (Zepzelca) Administration?
Lurbinectedin (Zepzelca) is an alkylating agent indicated for the maintenance treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) and for the treatment of patients with m...
509
Monday, November 24th, 2025, 09:53
Dosage and Administration of Lurbinectedin (Zepzelca)
Lurbinectedin (Zepzelca) is an innovative medication for the treatment of small cell lung cancer (SCLC). As a type of alkylating agent, it exerts antitumor activity through multiple mechanisms.Dosage ...
515
Monday, November 24th, 2025, 09:51
What are the purchasing channels for Lurbinectedin (Zepzelca)?
Lurbinectedin (Zepzelca) is an important medication for the treatment of small cell lung cancer (SCLC), providing new therapeutic options for patients with advanced disease. The proper acquisition and...
510
Monday, November 24th, 2025, 09:29
Side Effects of Ceritinib (Zykadia)
Ceritinib (Zykadia) is a kinase inhibitor indicated for the treatment of metastatic non-small cell lung cancer (NSCLC), specifically in adult patients whose tumors are confirmed as ALK-positive by an ...
505
Monday, November 24th, 2025, 09:24
What are the Precautions for Ceritinib (Zykadia) Administration?
Ceritinib (Zykadia) is a kinase inhibitor indicated for the treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC), as detected by a U.S. FDA-approved tes...
509
Monday, November 24th, 2025, 09:21
Dosage and Administration of Ceritinib (Zykadia)
Ceritinib (Zykadia) is a targeted therapy indicated for the treatment of anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). As a second-generation ALK inhibitor, ...
506
Monday, November 24th, 2025, 09:17
What are the Indications for Ceritinib (Zykadia)?
Ceritinib (Zykadia) is a targeted therapy developed by Novartis, specifically indicated for the treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations. As a crucial anticancer...
507
Monday, November 24th, 2025, 09:14
47 / 207
2065 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved